AI study to improve prostate cancer diagnosis with MRI and PSMA PET scans
Part of Cancer, Kidney & urinary clinical trials.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a performance status score of 0, 1, or 2 (meaning you can care for yourself and are up and about more than half of the day).
- Your life expectancy is more than 6 months.
- You have already had a special MRI (mpMRI) and a PSMA PET/CT scan before starting any treatment or prostate removal surgery, and the original digital copies of these scans are available.
- You have had a prostate biopsy or surgery to confirm prostate cancer (pathology result is available).
- Your complete medical records include your pre-treatment PSA, cancer stage, Gleason score, PI-RADS score, SUVmax, prostate size, age, and weight/BMI.
- You agree to let us use your medical data for this research, as approved by your center's ethics committee.
- You have no other history of cancer, no past prostate surgery (like TURP), no prior hormone therapy or radiation, and no severe kidney problems or major organ failure with a life expectancy less than 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer program that reads prostate MRI images to help doctors diagnose prostate cancer more accurately. It may help you by providing a clearer picture of your condition without extra tests.
This trial uses a special PET scan (PSMA PET) and artificial intelligence to see if we can detect prostate cancer without a needle biopsy. It is for men who are either already scheduled for a PET scan or who have symptoms or high PSA suggesting prostate cancer.
This study tests a new biopsy system that uses MRI images and metabolic information to guide doctors to the most suspicious areas of the prostate during the biopsy. This could make the biopsy more accurate and help diagnose prostate cancer better.
This study uses an artificial intelligence (AI) program to read MRI scans of the prostate and compare its findings with those of expert radiologists. The goal is to see if the AI can detect prostate cancer as accurately as the human experts, which might help in future diagnosis and treatment planning.
This trial studies whether a computer (AI) can better sort MRI results to improve prostate cancer diagnosis or classification. You may benefit by getting your multi-part MRI looked at in a new, more precise way, while helping researchers refine decision-making.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.